Role of Wnt Signalling in Advanced Prostate Cancer

Abstract
Recent next‐generation‐sequencing studies demonstrate that multiple pathways are often deregulated in advanced and metastatic prostate cancer (PC). In a recent issue of The Journal of Pathology, an elegant study by Jefferies et al used in vivo modelling to demonstrate how activation of the PI3K, WNT and MAPK pathway converges on mTORC1 signalling to drive aggressive disease. The study also highlights that approaches to target advanced PC require intelligent combination of agents to target single/multiple signalling pathways in combination with androgen receptor (AR) blockade.

Source: The Journal of Pathology - January 1, 2018 Category: Pathology Authors: Imran Ahmad, Owen J Sansom Tags: Invited Commentary Source Type: research